Clinical Trials Sponsored by Bayer

Total 2500 results

Clinical Research Center of the Carolinas
Bayer

Completed

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

Rosacea, Papulopustular

United States
Ortho-McNeil Janssen Scientific Affairs, LLC
Bayer

Completed

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

Arthritis | Osteoarthritis, Knee | Thromboembolism | Osteoarthritis, Hip

United States
Ohio State University Comprehensive Cancer Center
Bayer

Completed

CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas

Non-Hodgkin's Lymphoma

United States
The Methodist Hospital Research Institute
Bayer; Amgen

Completed

Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer

Carcinoma, Renal Cell

United States
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer

Venous Thrombosis | Deep Vein Thrombosis

Italy, Austria, Brazil, Hungary, Netherlands, South Africa, Israel, Australia, Germany
Bayer
Navitas Life Sciences GmbH; LKF Laboratory

Completed

Efficacy of Gynodian® Depot in Women With Impaired Well-being

Hormone Replacement Therapy
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis

Venous Thromboembolism

France, Italy, Czech Republic, Canada, Netherlands, Australia, United States, Poland, South Africa, Sweden, Israel, Denmark, Brazil
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study

Pulmonary Embolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Switzerland, United States, New Zealand, Poland, India, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Estonia, Thailand, Brazil, Germany, Korea, Republic... and more
Phramongkutklao College of Medicine and Hospital
Bayer

Terminated

The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias

Autoimmune Cytopenias

Thailand
Charite University, Berlin, Germany
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma; Center for Stroke...

Completed

Berlin Atrial Fibrillation Registry

Atrial Fibrillation | Acute Ischemic Stroke

Germany
University of Erlangen-Nürnberg Medical School
Bayer

Recruiting

Finerenone and Renal Oxidative Stress

Type2diabetes

Germany
Alberto Pilotto
Bayer

Recruiting

The European Registry of Older Subjects With Atrial Fibrillation (EUROSAF) (EUROSAF)

Atrial Fibrillation

Italy
Moorfields Eye Hospital NHS Foundation Trust
Bayer

Completed

Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study (AMOUR)

Retinitis Pigmentosa | Macular Oedema

United Kingdom
M.D. Anderson Cancer Center
Bayer; Xencor, Inc.

Withdrawn

Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)

Colorectal Cancer | Colon Cancer | Rectum Cancer

United States
Mario Negri Institute for Pharmacological Research
Bayer

Completed

Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes. (PAD&CAD)

Peripheral Artery Disease

Italy
Jing Liu
Bayer

Terminated

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness (NARRAS)

Hypertension

China
Northwestern University
National Cancer Institute (NCI); Bayer

Completed

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Ohio State University Comprehensive Cancer Center
Bayer

Terminated

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
University of Pittsburgh
Bayer; Shadyside Hospital Foundation

Terminated

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Clostridium Difficile-associated Diarrhea (CDAD)

United States
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients (MAGELLAN)

Venous Thromboembolism

Belgium, France, Norway, Spain, China, Taiwan, United States, Switzerland, Colombia, Canada, Estonia, New Zealand, Finland, Italy, Portugal, Japan, Singapore, Germany, Greece, Australia, Sweden, Austria, Chile, Slovakia, United Kingdom, M... and more
SCRI Development Innovations, LLC
Bayer; OSI Pharmaceuticals

Completed

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

Non-Small Cell Lung Cancer

United States
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Venous Thromboembolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, New Zealand, Poland, India, United States, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Taiwan, Brazil, Denmark, German... and more
Johnson & Johnson Pharmaceutical Research & Development...
Bayer

Completed

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Poland, Ukraine, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Colombia, Israel, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic... and more
Jae Ho Byun
Bayer

Withdrawn

Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver (PriMPa)

Liver Cirrhosis | Carcinoma, Hepatocellular

Korea, Republic of
University of Minnesota
Bayer; Gruessner, Rainer, MD

Terminated

Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation

Diabetes Mellitus

United States
Bayer

Completed

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

HIV Infections

United States
Bayero University Kano, Nigeria

Completed

Validation of Hausa Oswestry Disability Index, Numeric Pain Rating Scale, Roland-Morris Disability Questionnaire, SF-12 Health Survey, Pain Catastrophizing Scale, Fear-Avoidance Beliefs Questionnaire,Global Rating of Change Scale and Back Beliefs Questionnaire in Low Back Pain Patients

Chronic Low Back Pain

Nigeria
Bayero University Kano, Nigeria

Unknown

Intracervical Lidocaine Versus Intramuscular Diclofenac for Pain Relief in HSG in a Tertiary Hospital in Kano

Female Infertility of Tubal Origin

Nigeria
Bayero University Kano, Nigeria

Completed

Multifidus Activation, Pain and Functional Disability in Individuals With Chronic Low Back Pain (CMLBP)

Chronic Low Back Pain

Nigeria
Judge Baker Children's Center

Completed

Behavioral and Affective Skills in Coping (BASIC) Open Trial (BASIC)

Anxiety Disorders | Disruptive Behavior Disorders | Depressive Disorders

United States
Bayero University Kano, Nigeria

Recruiting

Effectiveness of Treadmill Walk on Chronic Low Back Pain

Chronic Low Back Pain

Nigeria
Bayero University Kano, Nigeria

Completed

Effectiveness of Paretic Lower Limb Loading During Over-ground Training Among Stroke Survivors

Stroke | Hemiparesis;Poststroke/CVA

Nigeria
Bayero University Kano, Nigeria

Completed

A Pilot Study of Motor Control Exercise and Patient Education for the Management of Chronic Low Back Pain in Rural Nigerian Community.

Chronic Low Back Pain

Nigeria
Rachel Baker

Completed

Skin-to Skin Contact on Newborn Temperature

Pregnancy | Skin to Skin Contact

United States
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Manisa Celal Bayar University

Completed

Emergency Classification According to Fingertip Circulation

Dyspnea

Turkey
Bayero University Kano, Nigeria

Completed

Patient Education and Motor Control Exercise Among Rural Community-dwelling Adults With Chronic Low Back Pain

Nonspecific Chronic Low Back Pain

Nigeria
Baker Heart Research Institute

Unknown

Cortisol and Nutritional Sympathetic Responsiveness

Obesity | Metabolic Syndrome | Insulin Resistance

Australia
Baker Heart Research Institute

Unknown

The Effects of Weight Loss on Neuroadrenergic Function

Obesity | Metabolic Syndrome | Type 2 Diabetes

Australia
San Francisco Veterans Affairs Medical Center
University of California, San Francisco; Bayer Healthcare Pharmaceuticals,...

Unknown

Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents

Hepatocellular Carcinoma

United States
University of Oxford
Bayer; Li Ka Shing Foundation

Recruiting

Reproductive Endocrinology Oxford Study (RepOx) (RepOx)

Polycystic Ovary Syndrome

United Kingdom
PD Dr. Andreas Strauß
Bayer

Recruiting

Osteoporosis and Haemophilia

Osteoporosis | Haemophilia | Bone Mass

Germany
Alexandra Kautzky-Willer
Bayer

Recruiting

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism (Test2Func)

Fatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes Mellitus

Austria
Center for Epidemiology and Health Research, Germany
Bayer

Active, not recruiting

European Active Surveillance Study of LCS12 (EURAS_LCS12)

Contraception

Germany
Navitas Life Sciences GmbH
GE Healthcare; Bayer; Guerbet

Completed

Long-Term Retention of Gadolinium in Bone

Focus: Long-term Retention of Gadolinium-based Contrast Agent

Spain, Korea, Republic of, United States, Germany, Japan, Turkey
Center for Epidemiology and Health Research, Germany
Bayer

Completed

Visanne Post-approval Observational Study (VIPOS)

Endometriosis

Germany
Rodwige J. Desnoyers
Bayer; Hoosier Cancer Research Network

Terminated

Efficacy of Ginseng for Patients on Regorafenib

Colorectal Cancer | Supportive Care | Palliative Medicine

United States
Hoosier Cancer Research Network
Bayer; Genentech, Inc.; Amgen

Terminated

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Massachusetts General Hospital
Bayer; Dana-Farber Cancer Institute

Completed

GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer
Daniela Matei, MD
Bayer; Hoosier Cancer Research Network

Terminated

Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer

Ovarian Cancer

United States

Clinical Trials Sponsored by Bayer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations